Cantor Fitzgerald Starts CoreSite Realty (COR) at Buy; Core Execution Critical
Get Alerts COR Hot Sheet
Price: $318.04 +1.06%
Rating Summary:
10 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
10 Buy, 16 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Cantor Fitzgerald initiates coverage on CoreSite Realty (NYSE: COR) with a Buy. PT $24.50.
Analyst, Sri Nagarajan, said, "While the core operational risks are higher compared to a well established name such as Digital Realty Trust (NYSE: NYSE: DLR)(SELL), we note that the company has increased portfolio occupancy by about 300 bps since September 2010. Despite less robust (flat) occupancy gains projected in 2012-13, we find COR’s valuation compelling."
For an analyst ratings summary and ratings history on CoreSite Realty click here. For more ratings news on CoreSite Realty click here.
Shares of CoreSite Realty closed at $21.04 yesterday.
Analyst, Sri Nagarajan, said, "While the core operational risks are higher compared to a well established name such as Digital Realty Trust (NYSE: NYSE: DLR)(SELL), we note that the company has increased portfolio occupancy by about 300 bps since September 2010. Despite less robust (flat) occupancy gains projected in 2012-13, we find COR’s valuation compelling."
For an analyst ratings summary and ratings history on CoreSite Realty click here. For more ratings news on CoreSite Realty click here.
Shares of CoreSite Realty closed at $21.04 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
- Keefe, Bruyette & Woods Resumes Bank of Nova Scotia (BNS:CN) (BNS) at Outperform
- Cantor Fitzgerald Starts Milestone Pharmaceuticals (MIST) at Overweight
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cantor FitzgeraldSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share